AML M1 was diagnosed and the treatment according to AML BFM 2019 was initiated, and the genetic work-out demonstrated chromosome 7 monosomy and loss-of-heterozygosity (LOH) of the whole q arm of chromosome 17 involving the NF1 gene. The gene discussed is NF1; the disease is acute myeloid leukemia.